Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in Switzerland
Patients who initiated vortioxetine for treating a major depressive episode experienced improvements in depressive symptoms and functioning. Vortioxetine was well tolerated. Underestimation of depressive episode severity by clinicians reinforces the importance of using rating scales in clinical practice.
Authors
- Gregor Hasler
- Axel Baumann
- Barbara Hochstrasser
- Alexandra Sousek
- Martin Kammerer
Institutions
- University of Fribourg (CH)
- Privatklinik Meiringen (CH)
- Lundbeck (Germany) (DE)
- Klinik und Poliklinik für Psychiatrie und Psychotherapie (DE)
- Imperial College London (GB)
Publication Details
- Journal
- Clinical Drug Investigation
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1007/s40261-026-01537-z
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- H. Lundbeck A/S